Navigation Links
While on trail of dioxin, scientists pinpoint cancer target of green tea

r, stopping the cascade of events that would lead to the activation of several harmful genes.

This weekend Palermo is receiving the Wallace Fenn Award, named after a long-time physiology professor at the University of Rochester School of Medicine and Dentistry. The award is given at graduation each year to a student who has produced an outstanding thesis. The research also has earned Palermo awards from the Society of Toxicology in each of the last three years; the current research was published in the April 5 issue of the journal Biochemistry. She is now a post-doctoral associate at Tulane, where she is looking into the causes of childhood leukemia.


'"/>

Source:University of Rochester Medical Center


Page: 1 2 3

Related biology news :

1. History-hunting geneticists can still follow familiar trail
2. Researchers hot on the trail of brain cell degeneration
3. Wisconsin scientists grow critical nerve cells
4. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
5. UAB scientists discover the origin of a mysterious physical force
6. Fox Chase Cancer Center scientists identify immune-system mutation
7. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
8. U-M scientists find genes that control growth of common skin cancer
9. UCLA scientists transform HIV into cancer-seeking missile
10. RNA project to create language for scientists worldwide
11. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals

Post Your Comments:
(Date:12/3/2009)...s to investment in energy efficient technologies r...earch Council (EPSRC) Chief Executive Dave Delpy b...eering research has already brought us fuel cells,...investment is needed to develop the capabilities o... emission targets by 2020 and limit the impact of ...
(Date:12/2/2009)... Latino men have a more difficult time quitting sm... culture, but acculturation has no affect on Latin...ings are published in Cancer Epidemiology, Biomar...ciation for Cancer Research. The December issue ha...ffects smoking cessation differently for Latino me...
(Date:12/2/2009)...olescents exposed to cigarette smoking scenes in m...ves, and this may be part of the acculturation pro... to new study findings. , "Our study supports an...hlights the global implementation of the World Hea...ontrol, which includes guidelines for countries to...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Acculturation affects smoking cessation success among Latinos 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation 5676 1Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation 5676 2Survival after heart attack improves in younger women 60050 1Survival after heart attack improves in younger women 60050 2Cell Therapeutics Inc 28CTI 29 to Present at 8th Annual BIO Investor Forum 5673 1
... that Xanex or Xanax? Or maybe Zantac? If you,re a...fference--mistakes can be fatal. , An estimated 1....jured each year from medication errors, and the U....ing to reduce the possibilities of these errors, s... an injection of Narcan but received Norcuron and ...
...the January 1 issue of Genes & Development, Dr... inhibitor, Mdm2, as a promising target for cancer...tical role in cancer formation, and many anticance...tumor formation. Mdm2 is a key inhibitor of p53 an...ctivity in cells. However, conflicting evidence ex...
... risk of serious suicide attempts or death by suic...s start taking antidepressant medication, accordin...esearchers and published in the January issue of T...found that the risk of suicidal behavior after sta...than the risk posed by older medications. , These...
Other Biology News:Computer scientist sorts out confusable drug names 2Suicide risk does not increase when adults start using antidepressants, study finds 2
(Date:12/2/2009)...Dec. 2 Peregrine Pharmac...pletion of patient enrollment in a dose confirmati... with relapsed glioblastoma multiforme (GBM), the ...ted monoclonal antibody linked to a radioisotope b...M. Cotara specifically targets cells at the cente...
(Date:12/2/2009)...bon, December 2 , - "Bols...and Heritage" , Coinciding with the Inter...abonese Republic is hosting an international confe...arding biological resources in Africa. The,confere...rs, ministers,scientific experts, private compani...
(Date:12/2/2009)...ss., Dec. 2 TechConnect World, an ...development and product integration in cleantech, ... 11th deadline for technology abstracts and busine...Connect World, in association with the Nano Scienc...echnology and Sustainable Industries Organization ...
(Date:12/2/2009)...c. 2 S*BIO Pte Ltd today announced...or, SB1518, at The American Society of Hematology ... ,, Data will be presented on the clinical resu...18 detailing its safety, tolerability and pharmaco...vels ranging from 100 to 600 mg. These doses were ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...een voiced across the state that the recent U.S. ...hree patents held by the patenting and licensing a...astating blow to the state,s acknowledged leadersh... who lodged the thus-far successful challenge agai...em cells held by the Wisconsin Alumni Research Fo...
...n ranks in the lower half of states in federal con... help researchers and companies land more federal ...earch Consortium , funded by a grant from the U.S...otentially lucrative territory - sensitive, classi...Wisconsin through research and development, said J...
...heme-based cities being developed at a phenomenal ...tities of such projects become nightmares. In size... a single large dwelling. , ,Now this requires a n...the customers with other traditional metropolises....City has become great success story, which extend...
Other Biology Technology:Patent ruling doesn't tarnish Wisconsin's stem cell leadership 2Patent ruling doesn't tarnish Wisconsin's stem cell leadership 3Research consortium aims to bring security and defense contracts to Wisconsin 2Branding around the community brand concept 2Branding around the community brand concept 3
MetaMorph from Universal Imaging Corporation (a subsidiary of Molecular Devices)
...olecular Devices is a fully-integrated true point-... and analysis of images for high throughput cell-b...taXpress, a complete software solution for screeni...ress enables users to select a standard image anal...
Varian 2200 Ion Trap GC/MS from Varian, Inc.
... quantification of the green complex formed betwee...te. The rapid color formation from the reaction ca...(600-660 nm) or on a plate reader. The non-radioac...o offer superior sensitivity and prolonged shelf l...
Biology Products: